In focus · trending topic

medical aesthetics

2 stories · following the connections

Sientra® to Release Third Quarter 2017 Financial Results

By Nasdaq OMXNov 3, 2017, 12:01 PM UTC

Topokine Initiates Phase 2 Trial of TAT4 Gel for Topical Reduction of Laugh Lines

By Nasdaq OMXJan 27, 2016, 1:30 PM UTC